All In MedTech

Device Trial Radar · NCT06651632

WATER IV Prostate Cancer

WATER IV Prostate Cancer: Aquablation Versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer

Last checked: Nov 19, 2026Latest source record: May 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 280 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

280

Planned (sponsor's estimate)

Start

Feb 3, 2025

Primary completion

Jul 2027

Study completion Jan 2037

Sponsor

Lead sponsor
PROCEPT BioRoboticsPublic (PRCT)
Sponsor type
Industry
First posted
Oct 22, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to either Aquablation Therapy or radical prostatectomy and followed up to 10 years.

Conditions

  • Localized Prostate Cancer

Interventions

  • Aquablation TherapyDevice

    The AquaBeam Robotic System and the HYDROS Robotic System utilize high-velocity sterile saline waterjet to resect prostate tissue, guided by real-time visualization through cystoscopy and transrectal ultrasound imaging. This minimally invasive surgical procedure is called the Aquablation therapy.

  • Radical ProstatectomyProcedure

    Radical prostatectomy is a surgery that is performed through an incision in the lower abdomen or perineum, or with a laparoscope or robotic system to remove the entire prostate gland.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of pad use for urinary incontinenceTime frame: 6 Months
  2. Rate of erectile dysfunctionTime frame: 6 Months

Locations

37 sites in 7 countries. Site status is shown where the registry gives one.

  • Arizona State Urological Institute

    Chandler, Arizona

  • East Valley Urology Center

    Mesa, Arizona

  • University of Southern California

    Los Angeles, California

34 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.